Literature DB >> 24983716

Increasing pyomyositis presentations among children in Queensland, Australia.

Paul Moriarty1, Clare Leung, Mark Walsh, Clare Nourse.   

Abstract

BACKGROUND: Pyomyositis, usually associated with tropical climates, occurs less commonly in temperate regions and is most often caused by Staphylococcus aureus. Several community-acquired methicillin-resistant S. aureus (CA-MRSA) clones have emerged in Queensland since the beginning of the century, and they now account for a significant proportion of invasive staphylococcal infection. This study aims to describe trends in the rate of presentation, and the clinical and diagnostic features of pyomyositis, and to determine if trends are attributed to the emergence of CA-MRSA or other factors.
METHODS: A 10-year retrospective cohort study of all patients presenting to Mater Children's Hospital in Brisbane, Queensland, with pyomyositis between July 2002 and July 2012, was conducted. Data were collected for clinical features, microbiology, diagnostic tests, management and outcome. Trends in incidence, and clinical and diagnostic features of pyomyositis were analyzed.
RESULTS: Thirty-four cases of pyomyositis were identified. There was a male predominance (79%), and the vertebro-pelvic muscles were most often affected. The rate of pyomyositis increased significantly during the study period from a rate of 2.04 cases per 10,000 emergency department admissions in the first quarter of the study, to 8.73 cases per 10,000 in the final quarter (peak rate 13.5 cases per 10,000 in 2008). A causative organism was identified in 22 cases, most commonly methicillin-susceptible S. aureus with CA-MRSA identified in 4 cases. Patients who required surgical intervention had longer hospital admission, longer time to resolution of inflammatory markers and a higher risk of complication at follow-up.
CONCLUSION: This study demonstrates an increasing incidence of pyomyositis in a temperate region, which is not attributable to the emergence of CA-MRSA. The reasons for this change in incidence are not clear.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 24983716     DOI: 10.1097/INF.0000000000000470

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  7 in total

1.  Pelvic pyomyositis in children: changing trends in occurrence and management.

Authors:  Manish Kiran; Saffwan Mohamed; Ashley Newton; Harvey George; Neeraj Garg; Colin Bruce
Journal:  Int Orthop       Date:  2017-12-30       Impact factor: 3.075

2.  Pelvic Pyomyositis in Childhood: Clinical and Radiological Findings in a Tertiary Pediatric Center.

Authors:  Giulia Abbati; Sarah Abu Rumeileh; Anna Perrone; Luisa Galli; Massimo Resti; Sandra Trapani
Journal:  Children (Basel)       Date:  2022-05-09

3.  Haemophilus influenzae Pyomyositis in a Patient with Diabetic Ketoacidosis: A Unique Case and Review of Literature.

Authors:  Kamolyut Lapumnuaypol; Sanna Fatima; Pradhum Ram; Gemlyn George; Antoinette Climaco
Journal:  Case Rep Infect Dis       Date:  2017-03-02

4.  Panton-Valentine leucocidin is the key determinant of Staphylococcus aureus pyomyositis in a bacterial GWAS.

Authors:  Bernadette C Young; Sarah G Earle; Sona Soeng; Poda Sar; Varun Kumar; Songly Hor; Vuthy Sar; Rachel Bousfield; Nicholas D Sanderson; Leanne Barker; Nicole Stoesser; Katherine Rw Emary; Christopher M Parry; Emma K Nickerson; Paul Turner; Rory Bowden; Derrick W Crook; David H Wyllie; Nicholas Pj Day; Daniel J Wilson; Catrin E Moore
Journal:  Elife       Date:  2019-02-22       Impact factor: 8.140

5.  Pyomyositis in Children.

Authors:  Sanjay Verma
Journal:  Curr Infect Dis Rep       Date:  2016-03       Impact factor: 3.725

6.  Iliopsoas Pyomyositis With Bacteremia at an Early Stage of Presentation in a Temperate Region.

Authors:  Shiho Amano; Ryuichi Ohta; Chiaki Sano
Journal:  Cureus       Date:  2022-07-14

7.  Magnetic resonance imaging in the evaluation of suspected hip sepsis in children.

Authors:  Nicole Corin; Simon Bennet; Joshua Hill; Simon Thomas
Journal:  J Child Orthop       Date:  2022-09-27       Impact factor: 1.917

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.